These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19802713)

  • 1. Telomere length predicts all-cause mortality in patients with type 1 diabetes.
    Astrup AS; Tarnow L; Jorsal A; Lajer M; Nzietchueng R; Benetos A; Rossing P; Parving HH
    Diabetologia; 2010 Jan; 53(1):45-8. PubMed ID: 19802713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.
    Tarnow L; Hildebrandt P; Hansen BV; Borch-Johnsen K; Parving HH
    Diabetologia; 2005 Jan; 48(1):149-55. PubMed ID: 15616804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes.
    Fyhrquist F; Tiitu A; Saijonmaa O; Forsblom C; Groop PH;
    J Intern Med; 2010 Mar; 267(3):278-86. PubMed ID: 19563389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Astrup AS; Tarnow L; Rossing P; Hansen BV; Hilsted J; Parving HH
    Diabetes Care; 2006 Feb; 29(2):334-9. PubMed ID: 16443883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
    Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.
    Astrup AS; Tarnow L; Rossing P; Pietraszek L; Riis Hansen P; Parving HH
    Kidney Int; 2005 Sep; 68(3):1250-7. PubMed ID: 16105058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
    Lajer M; Tarnow L; Jorsal A; Parving HH
    Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease.
    Tikkanen-Dolenc H; Wadén J; Forsblom C; Harjutsalo V; Thorn LM; Saraheimo M; Elonen N; Tikkanen HO; Groop PH;
    Diabetes Care; 2017 Dec; 40(12):1727-1732. PubMed ID: 29038314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Tarnow L; Astrup AS; Parving HH
    Scand J Clin Lab Invest Suppl; 2005; 240():73-9. PubMed ID: 16112962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
    J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up study.
    Astrup AS; Tarnow L; Christiansen M; Hansen PR; Parving HH; Rossing P
    Diabet Med; 2007 Dec; 24(12):1381-5. PubMed ID: 17971180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone synthase (CYP11B2) -344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients.
    Lajer M; Schjoedt KJ; Jacobsen P; Tarnow L; Parving HH
    Diabet Med; 2006 Jun; 23(6):675-80. PubMed ID: 16759311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Jorsal A; Tarnow L; Flyvbjerg A; Parving HH; Rossing P; Rasmussen LM
    Diabetologia; 2008 Nov; 51(11):2100-7. PubMed ID: 18719882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.
    Alkhalaf A; Bakker SJ; Bilo HJ; Gans RO; Navis GJ; Postmus D; Forsblom C; Groop PH; Vionnet N; Hadjadj S; Marre M; Parving HH; Rossing P; Tarnow L
    Diabetologia; 2010 Dec; 53(12):2562-8. PubMed ID: 20711718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.